BDBM476510 (2S)-1-[N2,N6-bis(1-methylethyl)-D- lysyl]-N-(3-chlorobenzyl)-4-[(4S,5S)- 4-methyl-5-phenyl-4,5-dihydro-1,3- oxazol-2-yl]piperazine-2-carboxamide::US10875851, Example 166

SMILES CC(C)NCCCC[C@@H](NC(C)C)C(=O)N1CCN(C2=N[C@@H](C)[C@H](c3ccccc3)O2)C[C@H]1C(=O)NCc1cccc(Cl)c1

InChI Key InChIKey=MGCGQEXVRSPLLS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476510   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476510BDBM476510((2S)-1-[N2,N6-bis(1-methylethyl)-D- lysyl]-N-(3-ch...)
Affinity DataIC50: 6.80nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent